ImmunSkills is a Swiss-based biotech start up with a mission to revolutionize cancer treatment. Our platform technology involves genetically modifying allogeneic natural killer cells to resist the tumor microenvironment (TME) and improve therapeutic outcomes in solid tumor patients. Today we are aiming at being a Contract Development and Manufacturing Organization (CDMO) offering a one-stop-shop solution for companies looking to develop new cell-based therapies targeting solid cancers. We plan to collaborate with our clients, introducing their CAR constructs into our cells and producing them at large scales. This will help our clients to de-risk their product development and accelerate their time to clinics or market.. To summarize, our clients only need to be sure about their CAR (i.e.the client’s CAR construct recognizes the tumor-specific antigen) and the rest in under ImmunSkills responsibilities Our platform technology has already shown promising results in-vitro. In order to finalize our proof of concept we intend to use a CAR-construct that has been developed at the University of Applied Sciences and targets pancreatic cancer cells. Following an eventual positive outcome of the project we may produce enough immune cells using our platform technology to initiate first studies in animal models. | ImmunSkills SA, located in Switzerland, is currently developing a cutting-edge platform for the manufacture of allogeneic cell therapies, specifically tailored for solid tumors. Our core innovation revolves around enhancing natural killer (NK) cells to withstand the hostile tumor microenvironment (TME) and to target cancer cells more effectively. These cells are engineered to incorporate chimeric antigen receptors (CARs), allowing for precise targeting of tumor-specific antigens. As a contract development and manufacturing organization (CDMO), we are focused on streamlining the development process for our clients, from initial cell line development to scalable, GMP-compliant manufacturing. Our upcoming facilities are designed to support rapid production scaling and to help biopharmaceutical companies and startups efficiently navigate the path from lab to clinical trials, optimizing both time and costs
Imerys
We lead the way in mineral-based specialty solutions for industry globally. Imerys supports a diverse range of sectors, from construction and automotive to consumer goods. Imerys multi-mineral portfolio of minerals make excellent reinforcing fillers, glass-fiber replacements and foaming agents in polypropylene, engineering thermoplastics and thermosets for the production of lightweight automotive parts, domestic appliances, electronic components, construction profiles and food packaging. | High-performance aerospace materials for space launch systems. | Imerys is a world leader in specialized graphite and carbon solutions for the production of batteries and fuel cells. Our C-NERGY® line of synthetic graphites and conductive carbon blacks is produced in Europe, meeting the highest standards of purity and quality to ensure peak electrochemical performance.Supporting the entire battery ecosystem, our portfolio features well-established brands including TIMREX® graphites, as well as SUPER P® Li and ENSACO® carbon blacks. We also offer high-performance ceramic materials—such as alumina, zirconia, and silica—engineered for use in battery cells, thermal interface materials, and fuel cells.To further strengthen the European battery value chain, Imerys has entered into a strategic partnership with Shanshan to develop a localized supply of high-performance synthetic graphite and advanced carbon nanotubes (CNTs). This collaboration combines Imerys’ European resources with world-leading technology to provide a secure, sustainable, and competitive local supply of essential battery materials. | Imerys is a world leader in specialized graphite, carbon, and advanced mineral solutions for the production of batteries and fuel cells.Our portfolio is engineered for next-generation performance. Key solutions include C-NERGY™ synthetic graphite for current collector coatings and silicone-rich anodes, and SUPER P® Li and ENSACO® conductive carbon blacks with high BET grades C130 and C600. Our materials are also well-suited to support the automotive industry’s shift to LFP batteries and the growing defense sector, including applications like drones.Through a collaboration with Cnano, we offer advanced Carbon Black-Carbon Nanotube Dispersions, leveraging their new plant currently being built in Kansas, USA. Our ZIONIC™ alumina, zirconia, and silica ceramics complete the portfolio, enhancing battery safety and thermal management.
illumicell AI
illumicell AI is building imaging + AI systems that read immune cell behavior — a foundation for faster drug development and truly personalized cancer treatments.
identic ai GmbH
identic ai is an ICT startup providing AI solutions for generating 3D and AR content from product images, primarily for retail. API integration and 3D content generation in one day, allowing sales boost. We also integrate with SketchUp 3D design platform to speed up the interior design process.
IDEAL-TEK S.A.
Founded in Switzerland in 1964, Ideal-tek has established itself as a leading global manufacturer of high-precision tools. Known for quality, precision, and reliability, Ideal-tek’s tweezers, pliers, cutters, and custom instruments are used daily by thousands of professionals worldwide. Key sectors include medical devices (such as neurovascular, cardiovascular and hearing applications), Life science (laboratories, universities, R&D centers), electronics and microelectronics, watchmaking, and more.From its facility in Ticino, Switzerland, Ideal-tek designs serves the needs of industries that require absolute precision. Ideal-tek also offers a range of tools, designed and developed internally and sourced from trusted suppliers. These include scissors, microscopes, scalpels, printed circuit board holders, and soldering/desoldering tools, ensuring customers have access to a complete suite of solutions for their workbenches.Ideal-tek’s products are available in more than 50 countries, thanks to a reliable network of over 150 distributor partners, making Swiss quality accessible to professionals across the globe.
Ideal-tek
Founded in Switzerland in 1964, Ideal-tek has established itself as a leading global manufacturer of high-precision tools. Known for quality, precision, and reliability, Ideal-tek’s tweezers, pliers, cutters, and custom instruments are used daily by thousands of professionals worldwide. Key sectors include electronics, microelectronics, medical devices (such as neurovascular, cardiovascular and hearing applications), Life science (laboratories, universities, R&D centers), watchmaking, and more.
ID Quantique
ID Quantique is the world leader in quantum cyber security and empowers researchers to create the quantum photonic building blocks of the Quantum Internet. The company provides Quantum Key Distribution and Quantum-Safe Key management solutions, QRNGs and Single Photon counters.
IBEX Therapeutics SA
Ibex Therapeutics is Swiss biotech company developing a patented oral topical therapy to cure and prevent oral mucositis and oral candidiasis, debilitating conditions which very often occur as adverse effect of cancer chemo- and radiotherapy and affects the care journey and the quality of life of cancer patients. A de-risked and short path to registration and commercialization by 2028, as validated by the German health authority BfArM: the lead product (containing 2 water-based plant extracts) is produced in GMP conditions and has confirmed its efficacy and safety in a pilot study in cancer patients. Ibex Tx is raising CHF 3 million, of which 1.0+ million has already received soft commitments, with the largest part of the proceeds to fund a final pivotal clinical study, and some portfolio extensions (including a probiotic to synergize with the oral topical therapy, and a spray presentation to augment portability and convenience of use by ambulatory patients). Strong market fundamentals: sustained medical need (increasing incidence of cancer and use of mucositis-inducing therapies), and absence of reference treatment. Further, Ibex Tx will register the product in several geographies (EU, USA, Asia, BRICS), and sign licensing agreements to ensure efficient commercialization outside of Switzerland.
I- Reversibles
We are Women’s Jackets – Rainwear, Fashion wear, All Types! Very moderately priced at $39.50